This is educational content about advertising regulations, not legal advice. Verify current requirements with your compliance counsel and state medical board.
Dermatology practice websites operate under overlapping jurisdiction from three regulatory bodies, each with distinct enforcement priorities and penalties.
Federal Trade Commission (FTC)
The FTC enforces truth-in-advertising standards under Section 5 of the FTC Act. For healthcare providers, this means every claim about treatment effectiveness must be substantiated by competent and reliable scientific evidence — typically peer-reviewed clinical studies or equivalent documentation. The Health Products Compliance Guidance released in recent years has increased scrutiny on aesthetic and wellness claims specifically.
Food and Drug Administration (FDA)
The FDA regulates claims about drugs, devices, and biologics. For dermatology practices, this primarily affects how you describe injectable treatments, laser devices, and prescription medications. You cannot claim a treatment does something beyond its FDA-cleared indications, and cosmetic procedures cannot be marketed as providing medical therapeutic benefits without appropriate clearance.
State Medical Boards
Your state medical board sets profession-specific advertising rules that often exceed federal requirements. These typically cover use of the term 'specialist,' comparative claims, fee advertising, and testimonial restrictions. Penalties range from letters of concern to license suspension.
The practical challenge is that compliant marketing requires satisfying all three simultaneously — and the strictest standard always applies.